We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pfizer and Bristol-Myers Squibb Finalize Worldwide Collaboration on Metabolic Disorders Program

News   Aug 27, 2007

 
Pfizer and Bristol-Myers Squibb Finalize Worldwide Collaboration on Metabolic Disorders Program
 
 
 

RELATED ARTICLES

It Is Possible to Extend Life Without Any Genetic Modification, Study Suggests

News

Given the relationship between telomeres and ageing - telomeres shorten throughout life, so older organisms have shorter telomeres -, scientists launched a study generating mice in which 100% of their cells had hyper-long telomeres.

READ MORE

A New Way of Creating the Building Blocks of Drugs

News

A team have discovered how to synthesize the most common molecule arrangement in medicine, a scientific discovery that could change the way a number of drugs are produced.

READ MORE

Time To Say Goodbye… to the “Household Measure” BMI?

News

A new study published in PLOS Biology sees an international collaboration of academia and industry experts introduce a novel "revolutionary" approach towards personalized and precision biomedicine, moving away from the "classic" morphometric BMI.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE